# Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)

> **NCT07119970** · NA · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 300 (estimated)

## Conditions studied

- Myeloproliferative Neoplasm
- Myeloproliferative Disorders

## Interventions

- **BIOLOGICAL:** Additional blood sampling

## Key facts

- **NCT ID:** NCT07119970
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-09
- **Primary completion:** 2028-12
- **Final completion:** 2030-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07119970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07119970, "Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07119970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*